Aceragen Inc (ACGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,867 | -23,360 | -12,584 | -9,485 | -4,178 |
| Depreciation Amortization | 11,074 | 15 | 11 | 8 | 4 |
| Income taxes - deferred | -273 | -6,318 | -6,039 | N/A | 0 |
| Accounts receivable | 2,005 | -2,294 | -49 | N/A | N/A |
| Other Working Capital | -1,619 | 781 | 5,853 | 233 | -961 |
| Other Operating Activity | 828 | 6,681 | 1,517 | 1,151 | 567 |
| Operating Cash Flow | $-9,852 | $-24,495 | $-11,291 | $-8,093 | $-4,568 |
| Cash Flows From Investing Activities | |||||
| Net Acquisitions | N/A | 5,482 | 5,482 | N/A | N/A |
| Investing Cash Flow | $0 | $5,482 | $5,482 | $0 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 88 | 64 | 59 | 28 | 16 |
| Other Financing Activity | -162 | -1,552 | 0 | 0 | 0 |
| Financing Cash Flow | $-74 | $-1,488 | $59 | $28 | $16 |
| Beginning Cash Position | 12,044 | 32,545 | 32,545 | 32,545 | 32,545 |
| End Cash Position | 2,118 | 12,044 | 26,795 | 24,480 | 27,993 |
| Net Cash Flow | $-9,926 | $-20,501 | $-5,750 | $-8,065 | $-4,552 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,852 | -24,495 | -11,291 | -8,093 | -4,568 |
| Free Cash Flow | -9,852 | -24,495 | -11,291 | -8,093 | -4,568 |